首页> 美国卫生研究院文献>Infection and Immunity >Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
【2h】

Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

机译:产生灭活霍乱毒素类似物的重组霍乱弧菌菌株的构建和鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The catalytic A subunit of cholera toxin (CT-A) is capable of ADP-ribosylating the guanine nucleotide-binding protein, which regulates cell adenylyl cyclase, leading to the life-threatening diarrhea of cholera. Amino acids involved in the enzymatic activity of CT-A have previously been identified. By means of site-directed mutagenesis, an analog of the CT-A subunit gene was created with codon substitutions for both Arg-7 and Glu-112, each of which has been shown to produce subunits lacking ADP-ribosyltransferase activity. The mutated gene fragment was exchanged for the wild-type copy in the previously cloned ctxAB operon from El Tor biotype, Ogawa serotype Vibrio cholerae strain 3083, which produces CT-2. Further, the zonula occludens toxin gene, zot, was inactivated by an insertional mutation to create the new plasmid construct pCT-2*. Additionally, a DNA fragment encoding the B subunit of CT-1 (CT produced by classical biotype, Inaba serotype V. cholerae strain 569B) was exchanged for the homologous part in pCT-2*, resulting in the creation of pCT-1*. These plasmid constructs were introduced into the CT-negative V. cholerae mutant strain JBK70 (E1 Tor biotype, Inaba serotype); CT-A-B+ derivatives CVD101 and CVD103 of classical biotype Ogawa and Inaba serotype strains 395 and 569B, respectively; El Tor biotype Inaba and Ogawa serotype strains C6706 and C7258, respectively, recently isolated in Peru; and O139 (synonym Bengal) strain SG25-1 from the current epidemic in India. Recombinant toxins (CT-1* and CT-2*), partially purified from culture supernatants of transformed JBK70, were shown to be inactive on mouse Y1 adrenal tumor cells and in an in vitro ADP-ribosyltransferase assay. CT-1* and CT-2* reacted with polyclonal and monoclonal antibodies against both A and B subunits of CT. The toxin analogs reacted with antibodies against CT-A and CT-B on cellulose acetate strips and in a GM1 enzyme-linked immunosorbent assay; they reacted appropriately with B-subunit epitype-specific monoclonal antibodies in checkerboard immunoblots, and they formed precipitin bands with GM1-ganglioside in Ouchterlony tests. However, the reactions of the modified proteins with anti-A-subunit monoclonal antibodies were weaker than the reactions with wild-type holotoxins. V, cholerae strains carrying ctxA*, with either ctxB-1 or ctxB-2, and inactivated zot genes were created by homologous recombination. The recombinant strains and the purified toxin analogs were inactive in the infant rabbit animal model.(ABSTRACT TRUNCATED AT 400 WORDS)
机译:霍乱毒素的催化A亚基(CT-A)能够将鸟嘌呤核苷酸结合蛋白的ADP-核糖基化,从而调节细胞腺苷酸环化酶,导致威胁生命的霍乱腹泻。先前已经确定了涉及CT-A的酶促活性的氨基酸。通过定点诱变,创建了具有Arg-7和Glu-112密码子替代的CT-A亚基基因类似物,已显示它们各自产生缺乏ADP-核糖基转移酶活性的亚基。将突变的基因片段换成先前克隆的来自El Tor生物型Ogawa血清型霍乱弧菌菌株3083的ctxAB操纵子中的野生型拷贝,该菌株产生CT-2。此外,通过插入突变使小带闭塞毒素基因zot失活,以创建新的质粒构建体pCT-2 *。另外,将编码CT-1的B亚基的DNA片段(由经典生物型的Inaba血清型霍乱弧菌菌株569B产生的CT)交换为pCT-2 *中的同源部分,从而产生了pCT-1 *。将这些质粒构建体引入CT阴性霍乱弧菌突变株JBK70(E1 Tor生物型,Inaba血清型);经典生物型小川和Inaba血清型菌株395和569B的CT-A-B +衍生物CVD101和CVD103;最近在秘鲁分离出的El Tor生物型Inaba和小川血清型菌株C6706和C7258; O139(同义词Bengal)菌株SG25-1来自印度当前的流行病。从转化的JBK70的培养上清液中部分纯化的重组毒素(CT-1 *和CT-2 *)在小鼠Y1肾上腺肿瘤细胞和体外ADP-核糖基转移酶测定中均显示为无活性。 CT-1 *和CT-2 *与针对CT的A和B亚基的多克隆和单克隆抗体反应。毒素类似物在醋酸纤维素条上和GM1酶联免疫吸附试验中与针对CT-A和CT-B的抗体反应;它们在棋盘免疫印迹中与B亚基表型特异性单克隆抗体发生了适当反应,并在Ouchterlony测试中与GM1-神经节苷脂形成沉淀蛋白条带。但是,修饰的蛋白与抗A亚基单克隆抗体的反应比与野生型全毒素的反应弱。 V,携带带有ctxB-1或ctxB-2的ctxA *的霍乱菌株和灭活的zot基因通过同源重组产生。重组菌株和纯化的毒素类似物在婴儿兔子动物模型中没有活性。(摘要截短为400字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号